HERCULES, CA--(Marketwire - November 12, 2007) - Bio-Rad Laboratories, Inc. (AMEX: BIO) and (AMEX: BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of the in2it™ analyzer for the “point-of-care” market. The in2it analyzer measures A1C, a well established indicator of a diabetic patient’s glucose control, and offers healthcare professionals greater efficiency and convenience by providing laboratory-accurate A1C test results -- while the patient waits.
